BN Business News
Add your company to Business Communicator →

Business · 06/09/2024Updated: 10/17/2026 · 1 min read

FDA Announces Public Advisory Committee Meeting for Elamipretide Hydrochloride Injection

Summary

The FDA is hosting a public meeting of the Cardiovascular and Renal Drugs Advisory Committee to discuss a new drug application for Elamipretide Hydrochloride Injection, and is seeking public comments on the proposal.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →